Theravance Biopharma (TBPH) Shares Outstanding (2013 - 2026)

Theravance Biopharma (TBPH) has reported Shares Outstanding (Entity) for 14 consecutive years, with $51.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 3.03% year-over-year to $51.5 million; the TTM figure through Mar 2026 stood at $51.5 million (up 3.03% YoY), while the FY2025 annual figure was $51.1 million, up 3.23% from the prior year.
• Shares Outstanding (Entity) improved to $51.5 million in Q1 2026 per TBPH's latest filing, from $51.1 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $76.4 million in Q2 2022 and bottomed at $48.1 million in Q4 2023.
• Historically, Shares Outstanding (Entity) has averaged $55.8 million across 5 years, with a median of $50.8 million in 2023.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) gained 16.66% — and 2023, when it decreased 29.74%.
• Theravance Biopharma's Shares Outstanding (Entity) stood at $65.2 million in 2022, then declined by 26.27% to $48.1 million in 2023, then advanced by 2.87% to $49.5 million in 2024, then increased by 3.23% to $51.1 million in 2025, then grew by 0.87% to $51.5 million in 2026.
• Business Quant data shows TBPH's Shares Outstanding (Entity) at $51.5 million in Q1 2026, $51.1 million in Q4 2025, and $50.7 million in Q3 2025.